The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary Amines

Author： Krueger Sharon   VanDyke Jonathan   Williams David   Hines Ronald  

Publisher： Informa Healthcare

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.38, Iss.1-2, 2006-05, pp. : 139-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Flavin-Containing Monooxygenase Substrate Specificity and Role in Drug Metabolism

By  

Current Drug Metabolism, Vol. 1, Iss. 2, 2000-09 ,pp. : 181-191

Bentham Science Publishers

Access to resources Recommend Favorite

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism

By Cashman John R  

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite

Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development

By Koukouritaki Sevasti B   Hines Ronald N  

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 807-822

Future Medicine

Access to resources Recommend Favorite

Biochemical and Clinical Aspects of the Human Flavin-Containing Monooxygenase Form 3 (FMO3) Related to Trimethylaminuria

By  

Current Drug Metabolism, Vol. 4, Iss. 2, 2003-04 ,pp. : 151-170

Bentham Science Publishers

Access to resources Recommend Favorite

Flavin Mono-Oxygenase (FMO) - The ‘Other’ Oxidase

By  

Current Drug Metabolism, Vol. 9, Iss. 4, 2008-05 ,pp. : 280-284

Bentham Science Publishers

Access to resources Recommend Favorite